-
Understanding Insufficient GLP-1 Activity in T2D
- 2022/01/03
- 再生時間： 9 分
- ポッドキャスト
-
サマリー
あらすじ・解説
What is the impact of insufficient GLP-1 activity in type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.
This podcast is sponsored by Novo Nordisk and is intended for clinicians.
Faculty Presenters:
John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee
Javier Morales, MD, FACP, FACE
Internal Medicine, Diabetes, and Primary Care
Associate Clinical Professor
Hofstra/Northwell School of Medicine at the Donald and Barbara Zucker School of Medicine
Long Island, New York
Richard E. Pratley, MD
Internal Medicine and Diabetes
AdventHealth Diabetes Institute
Orlando, Florida